جست‌وجوی استاد و پژوهشگر

• Burn Surgery
• Critical Care
• Trauma Surgery
• +۳ مورد دیگر

Dr. Irma D. Fleming serves as an Assistant Professor of Surgery at the University of Utah School of Medicine, where she maintains clinical practice at the University of Utah Hospital Burn Center in Salt Lake City. Board certified by the American Board of Surgery and its Surgical Critical Care subspecialty, she specializes in acute burn care, burn reconstruction, critical care trauma management, and necrotizing soft tissue infections. Her academic training includes: B.S. in Biology from Spelman College M.D. from Meharry Medical College General Surgery Residency at the University of Chicago Burn Surgery Fellowship at Vanderbilt University Medical Center Anesthesia Critical Care Fellowship at the University of Chicago Dr. Fleming's research integrates clinical burn care with microbiome science, focusing on how microbial communities influence wound healing, sepsis, and surgical outcomes. Her work examines nutritional interventions in burn recovery, electrical injury complications, frostbite management, and antibiotic-resistant pathogens in burn units. She investigates the intersection of trauma, critical illness, and host-microbe interactions using multi-omic approaches and clinical database analysis. Analysis of her 15 most recent publications (2016-2024) reveals consistent emphasis on burn care optimization through microbiome modulation, infection control in burn units, and metabolic/nutritional support. Key trends include translational studies on fecal microbiota transplants for sepsis, outbreak management of multidrug-resistant Acinetobacter baumannii, and innovative techniques like botulinum toxin application in acute burn care. Her work spans clinical trials, multi-omic tissue analysis, and hospital environmental microbiome studies. No scientific awards were documented in the provided materials. While no student mentorship or grant details were specified, Dr. Fleming's collaborative publications suggest active participation in multi-institutional research teams focused on surgical infections and critical care outcomes. Her clinical role involves telemedicine applications and comprehensive burn center care coordination.

Lin Suمشاهده پروفایل

مدرس

• Synthetic Biology
• Engineering Biology
• Biohybrid Systems
• +۳ مورد دیگر

Dr. Lin Su is a Lecturer in Engineering Biology at Queen Mary University of London, leading the Biohybrids group. His research focuses on biohybrid systems in synthetic biology, particularly electron transfer mechanisms between microorganisms and materials, with applications in bioelectrical systems and artificial photosynthesis. Dr. Su holds a PhD in Biomedical Engineering from Southeast University (2021), with postdoctoral research at the University of Cambridge (2021–present). His work includes collaborations with Lawrence Berkeley National Lab and Rice University (2016–2021). He is a Leverhulme Early Career Fellow (2022–2025) and an Isaac Newton Trust Grant recipient. He also serves as a Fellow at Lucy Cavendish College, Cambridge. Research interests span synthetic biology, microbial-material interfaces, and energy-related bioengineering. His lab develops novel platforms integrating living and non-living components for sustainable technologies. Awards: Leverhulme Early Career Fellowship Isaac Newton Trust Grant Fellow of Lucy Cavendish College Grants: Collaborative funding via Leverhulme Trust and Isaac Newton Trust. Labs/Teams: Director of the Biohybrids Group (https://biohybrids.group/), focusing on interdisciplinary engineering-biology research.

Bei Beiمشاهده پروفایل

دانشیار

• Sleep Disorders
• Circadian Rhythm
• Clinical Psychology
• +۵ مورد دیگر

Dr. Bei Bei is an Associate Professor at the School of Psychological Sciences, Monash University, and an NHMRC Emerging Leadership (EL2) Fellow. She leads the Behavioural Sleep Medicine service, research, and training at Monash University Healthy Sleep Clinic, focusing on individual differences in sleep-wake behaviors, sleep-mental health relationships, and community dissemination of evidence-based sleep interventions. Doctor of Psychology (Clinical), University of Melbourne PhD, University of Melbourne Her research spans six major areas: Sleep-wake circadian rhythm disorders Cognitive Behavioral Therapy for Insomnia (CBT-I) Psychological/behavioral aspects of sleep Sleep-mental health interactions (mood, anxiety) Adolescent sleep patterns and wellbeing Perinatal/postpartum sleep interventions for women Recent publications (2024-2025) address: Insomnia treatment mechanisms in depression comorbidity Neurodevelopmental impacts of circadian factors Pregnancy-related insomnia risk identification Adolescent sleep facilitators/barriers Integrated models for youth depression and sleep across continents She also contributes to: Antifungal drug tolerance mechanisms RNA polyadenylation dynamics Mitochondrial RNA stability in cancer 3' UTR splice variants in rare diseases Awarded the NHMRC Emerging Leadership (EL2) Fellowship and Early Career Research Grant , Dr. Bei serves on editorial boards for Sleep Medicine Reviews, Sleep, and Behavioral Sleep Medicine journals.

Priyanka Pundirمشاهده پروفایل

استادیار

• Immunology
• Microbiology
• Innate Immunity
• +۳ مورد دیگر

Priyanka Pundir is an Assistant Professor in the Department of Molecular and Cellular Biology at the University of Guelph. Her research focuses on innate immunity, particularly mast cell-mediated host-microbe interactions, and the role of G protein-coupled receptors (GPCRs) in immune responses against infections. She holds a B.V.Sc. from G. B. Pant University of Agriculture & Technology, a Ph.D. from the Atlantic Veterinary College (University of Prince Edward Island), and completed postdoctoral training at Johns Hopkins University. Education: B.V.Sc. – College of Veterinary Sciences, G. B. Pant University of Agriculture & Technology Ph.D. – Atlantic Veterinary College, University of Prince Edward Island Postdoctoral Fellowship – School of Medicine, Johns Hopkins University Her lab investigates how mast cells detect microbial signals (e.g., quorum-sensing molecules) and trigger immune defenses. Key discoveries include identifying the Mrgprb2 receptor’s role in antibacterial immunity and its implications for therapeutic development. Current projects explore neuroimmune interactions during infections and the functions of orphan Mrgprs. Her lab actively recruits motivated students and offers a PhD position starting in 2024. Contact: ppundir@uoguelph.ca .

• Sepsis
• Innate Immunity
• Neonatal Immunology
• +۵ مورد دیگر

Andrew Currie is a Professor and Associate Dean (Research & Innovation) at Murdoch University's School of Medical, Molecular and Forensic Sciences, within the College of Environmental and Life Sciences. He leads the Sepsis Diagnostics Research Group at the Centre for Molecular Medicine and Innovative Therapeutics and co-heads the Neonatal Infection and Immunity Team with Clinical Professor Tobias Strunk at the Wesfarmers Centre of Vaccine & Infectious Diseases at Telethon Kids Institute. His research focuses on immunology and infectious diseases in pediatric populations, particularly sepsis diagnostics and neonatal immunity. Education: PhD (Immunology, University of Western Australia, 2001); BSc (Biotechnology with Honors, Murdoch University, 1997). Research Interests: Sepsis diagnostics, innate immunity mechanisms in neonates, medical biotechnology for diagnostics (e.g., biosensors), and translational research in pediatric infections. Collaborates internationally with institutions in Canada, Denmark, the UK, US, and China. Aims to reduce sepsis burden in vulnerable populations through advanced molecular methods and interdisciplinary partnerships. Key Affiliations: Lead of Sepsis Diagnostics Research Group (Murdoch University), Senior Lecturer in Immunology, Honorary Associate at Kids Research Institute Australia. Past roles include leadership in the Centre for Molecular Medicine and Innovative Therapeutics. Scientific Contributions: Over 100 peer-reviewed articles focusing on sepsis biomarkers, neonatal immunity, tick-borne diseases, and clinical trials for interventions like vitamin C and probiotics in critical illness. Active in developing precision medicine approaches for neonatal sepsis. Grants & Funding: Co-leads major projects on sepsis diagnostics and neonatal infection, supported by national and international grants. Collaborates on multi-institutional initiatives. Labs/Teams: Sepsis Diagnostics Research Group (Murdoch) and Neonatal Infection and Immunity Team (Telethon Kids Institute). Works closely with the Personalised Medicine Centre and Health Futures Institute.

Andrew McArthurمشاهده پروفایل

استاد

• Bioinformatics
• Genomics
• Antimicrobial Resistance
• +۵ مورد دیگر

Andrew McArthur is a Professor in the Department of Biochemistry & Biomedical Sciences at McMaster University, where he leads the McArthur Laboratory. His research focuses on bioinformatics , genomics , and computational biology with a specialization in genomic surveillance of antimicrobial resistance (AMR) . He spearheads the Comprehensive Antibiotic Resistance Database (CARD) and collaborates with the Canadian Anti-Infective Innovation Network (CAIN) , GenEpio Consortium , and IRIDA Platform for pathogen genomics. Education : PhD in Biochemistry (University of Victoria, 1996), Postdoctoral work at Marine Biological Laboratory (1998-1999) and National Museum of Natural History (1996-1998) His research spans antimicrobial resistance surveillance , machine learning applications , viral genomics (including SARS-CoV-2), and pathogen evolution . He has developed tools like CARD and IRIDA to standardize AMR data and enable rapid infectious disease analysis. Recent work includes machine learning models for predicting AMR, cloud-based pathogen detection , and resistome profiling in clinical and environmental contexts. He has mentored graduate students including Jalees Nasir (HSGSA Impact Award 2025), Dirk Hackenberger , Autumn Arnold , and Emily Bordeleau , as well as postdoctoral fellows like Sheridan Baker . His teaching includes courses in practical bioinformatics and biomedical consulting at McMaster University.

Janin Chandraمشاهده پروفایل

عضو هیئت علمی

• Immunology
• Cancer Research
• Virology
• +۴ مورد دیگر

Dr. Janin Chandra is a Senior Research Fellow at the Frazer Institute, University of Queensland, leading her own lab since 2023. Her research focuses on immune regulation in HPV-driven cancers, antigen-presenting cells, and squamous cell carcinomas. She holds a PhD in Immunology from the University of Zurich and has extensive postdoctoral experience at UQ and biotech companies like Admedus Vaccines. She has published over 35 journal articles, contributed to clinical trials, and received the Garnett Passe Mid-Career Fellowship (2023–2027). Education: Master of Science (Goethe University, Frankfurt), PhD (University of Zurich). Research highlights include developing HPV vaccines, studying immune suppression mechanisms, and investigating Langerhans cell dysfunction in tumors. Her work bridges immunology and oncology, targeting therapies to modulate antigen-presenting cells. Research Interests : HPV-induced immune evasion mechanisms Antigen-presenting cell biology in cancer Clinical development of DNA vaccines Immune microenvironment of head/neck and cutaneous cancers Grants & Awards : Current funding includes targeting cancer-associated fibroblasts (Garnett Passe Fellowship). Past grants involve microbiome analysis and vaccine development. Lab Activities : Her lab investigates intra-tumor immune regulations and develops novel immunotherapies. Collaborations span veterinary oncology and microbiome research.

Jenny PY Tingمشاهده پروفایل

استاد

• Innate Immunity
• Immunology
• Inflammation
• +۷ مورد دیگر

Jenny PY Ting, PhD, is the William R. Kenan, Jr. Distinguished Professor of Genetics at the UNC School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center. She serves as Director of the Center for Translational Immunology and Co-Director of the Inflammatory Diseases Institute. Her research focuses on innate immunity, inflammation, and the molecular mechanisms underlying autoimmune diseases, cancer, and neuroinflammation. Dr. Ting's lab investigates the NLR protein family, particularly their roles in inflammasome activation, MHC regulation, and microbial sensing. She has discovered critical functions of NLRC5 and CIITA in immune gene transcription and pioneered studies on plexin-semaphorin signaling in immune cell interactions. Her work on SARS-CoV-2 revealed necroptosis-driven cell death cascades in airway cells, informing therapeutic strategies against cytokine storms. Key Projects: Microbiome-based therapies for multiple sclerosis Targeting NLRP3 inflammasomes in inflammatory diseases Role of plexins in T cell activation and sepsis Awards: National Academy of Sciences member (2022), AAI Distinguished Fellow (2023), ICIS-Pfizer Award (2021). Her lab employs cutting-edge techniques including transcriptomics, proteomics, and murine models. Collaborations span virology, oncology, and neurobiology, with translational goals for immune-based therapies.

Patrick M. Tarwaterمشاهده پروفایل

استاد

• Infectious Disease Epidemiology
• Traumatic Brain Injury Rehabilitation and Sleep
• Biostatistical Methods in Comparative Pathobiology
• +۱ مورد دیگر

Patrick M. Tarwater is a Professor in the Department of Epidemiology & Biostatistics at Texas A&M University, with research spanning infectious disease epidemiology, traumatic brain injury rehabilitation, sleep science, biostatistical methods, and environmental health impacts on child development. His work integrates clinical, laboratory, and computational approaches to address complex public health challenges. His educational foundation includes: PhD in Biometry from University of Texas Health Science Center at Houston (1999) MS in Mathematics from Texas Tech University (1992) BA in Mathematics from Texas Tech University (1990) Tarwater's research in Infectious Disease Epidemiology features extensive work on HIV/SIV pathogenesis using non-human primate models, SARS-CoV-2 variant dynamics, and microbial risk assessment in environmental settings. His Traumatic Brain Injury and Sleep research includes innovative interventions like the OSABI sleep hygiene protocol and objective sleep monitoring methodologies for rehabilitation patients. The Environmental Health focus centers on the ECHO program's investigation of maternal nutrition and child health outcomes, alongside risk assessments for oil spill contaminants and recreational water safety. Analysis of his 2018-2024 publications reveals three dominant trajectories: (1) viral pathogenesis mechanisms using advanced animal models, (2) neuroimmunological consequences of infections and injuries, and (3) environmental exposure risk modeling. His work consistently employs sophisticated biostatistical techniques and translational approaches bridging laboratory findings to clinical applications. While no specific awards are documented in the source material, Tarwater's prolific publication record in high-impact journals demonstrates significant scholarly contributions. His teaching portfolio includes foundational courses in epidemiology and biostatistics, plus advanced instruction in cohort analysis and epidemiologic inference.

• Vaccinology
• Pediatric Infectious Diseases
• Clinical Epidemiology
• +۴ مورد دیگر

Dr. Eugene Shapiro is a Professor at Yale University since 1983, holding appointments in Pediatrics (Infectious Diseases) and Epidemiology (Microbial Diseases). He serves as Vice Chair for Research in the Department of Pediatrics, Deputy Director of the PhD Program in Investigative Medicine, and Co-Director of Education at the Yale Center for Clinical Investigation. B.A. in English Literature, Yale College (1970) M.D., University of California, San Francisco (1976) His research focuses on vaccinology , particularly Lyme disease and RSV vaccines , with over 250 publications. He has led NIH-funded R01 grants and served on WHO and FDA vaccine advisory boards. Recent publications highlight work on RSV vaccine efficacy , updated pneumococcal vaccines , and tick-borne infections in children . His 2014 and 2017 awards recognize contributions to vaccinology and pediatric infectious diseases. Email: eugene.shapiro@yale.edu Academic Office: 789 Howard Avenue, Ste 14C, New Haven, CT

• HIV Research
• Virology
• Immunology
• +۳ مورد دیگر

Yulong Wei is a Researcher in the Department of Microbial Pathogenesis at Yale School of Medicine. His work focuses on understanding viral persistence mechanisms, particularly in HIV-1 and SARS-CoV-2, using cutting-edge genomic and immunological approaches. He explores how host cellular environments influence viral integration, reservoir formation, and immune evasion. Research interests include: HIV reservoir dynamics and latency mechanisms Host-pathogen interactions in viral persistence Single-cell multiomics analysis of viral infections Antiviral drug discovery and repurposing Ribosomal adaptation and translation mechanisms in bacteria Recent work highlights his contributions to understanding how interferon signaling and chromatin structure affect HIV integration sites, as well as computational studies of griseofulvin's potential in combating SARS-CoV-2. He has also investigated evolutionary genomic signatures in microbes related to translation efficiency and environmental adaptation. His lab is part of the Yale School of Medicine's broader efforts in microbial pathogenesis and infectious disease research, with a focus on translational applications for persistent viral infections.

• Medical Mycology
• Antimicrobial Resistance
• Infectious Diseases
• +۴ مورد دیگر

Dr. Maryam Roudbary is an Adjunct Senior Lecturer at the Westmead Clinical School, part of the Sydney Medical School, University of Sydney. She joined the Sydney Infectious Diseases Institute (Sydney ID) in 2023 as a researcher affiliated with the University of Sydney and employed by NSW Health and Research Network as a Senior Researcher in Mycology. Previously, she served as an Associate Professor at Iran University of Medical Sciences (2015–2022), leading research projects and supervising Master’s and PhD students in medical mycology and fungal infections. Her PhD in Medical Mycology focused on antifungal resistance mechanisms and new therapeutic strategies. Current research priorities include developing novel antifungal agents against drug-resistant fungi, understanding resistance mechanisms, and addressing challenges outlined in the WHO’s 2022 Fungal Priority Pathogen List. She is an editor for several mycology journals and co-authored The Book of Fungal Pathogens (2022). Roudbary’s work spans epidemiological studies, clinical sampling, and collaborations in One Health AMR initiatives. She leads projects on fungal diversity exploration (e.g., Vietnam citizen science initiatives) and evaluates natural compounds (e.g., thymus extracts, nanoparticles) for antifungal efficacy. Recent grants include a 2025 project on antifungal peptide-based therapeutics. Her research emphasizes biofilm formation in filamentous fungi, Candida species pathogenesis, and fungal co-infections in immunocompromised patients, including those with severe COVID-19. Key findings include the prevalence of azole-resistant Candida species in Iran and the role of gene expression (e.g., CDR1 , HWP1 ) in drug resistance. Roudbary’s contributions include over 100 peer-reviewed articles, grants focusing on antifungal innovation, and active roles in international mycology networks. She bridges clinical and research domains through translational studies targeting critical fungal health challenges.

• Neurosciences
• Physiology
• Microbiology
• +۵ مورد دیگر

Professor Elisa Hill is a distinguished academic at RMIT University where she serves as a Professor in the Department of Health and Biomedical Sciences within the College of Science. She leads the Gut-Brain Axis Laboratory and holds the significant position of Deputy Chair of the Academic Board at RMIT University. Her career spans prestigious institutions including The University of Melbourne and research collaborations in Paris, France. Professor Hill earned her PhD in Neuroscience from The University of Melbourne in 2002. She subsequently undertook a CNRS postdoctoral position in Paris studying cortical neuronal diversity. Returning to Melbourne in 2006 as an NHMRC Howard Florey Centenary Fellow, she joined Prof Steve Petrou's laboratory to investigate neuronal networks in genetic mouse models of epilepsy. In 2009, she imported the Neuroligin-3R451C mouse model of autism to Australia, establishing herself as a pioneer in gut-brain axis research. Her research program focuses on three interconnected areas: identifying causes of gut dysfunction in transgenic mouse models of neurological disease, determining how neurons communicate with the lymphoid system and inflammation, and understanding interactions between the nervous system and bacteria. Professor Hill has demonstrated that gene variations associated with autism alter neuron populations in the mouse enteric nervous system, affecting gut motility, permeability, microbiome composition, and behavior. Her laboratory has developed sophisticated capabilities including video-imaging assays for gut motility, immunofluorescence for neuronal and immune cell analysis, and whole-cell patch clamp electrophysiology for neuronal activity profiling. Analysis of her recent publications reveals a strong focus on the gut-brain axis in autism, with particular attention to the Neuroligin-3R451C mouse model. Her work spans neuroimmunology, gastrointestinal physiology, microbiome interactions, and behavioral neuroscience, demonstrating an increasingly interdisciplinary approach that integrates molecular, cellular, and systems-level perspectives. A notable trend is the expansion of her research into translational applications, including biomaterial development for urogynaecological health. NHMMRC Howard Florey Centenary Fellowship ARC Future Fellowship RMIT Senior Vice Chancellor's Research Fellowship Professor Hill actively supervises numerous PhD students including Vic Lin, Yuansong Li, and Mohammed Al Alamoudi, among others. Her research has been supported by major funding bodies including NHMRC, US Department of Defense CDMRP, CNRS, ARC, and RMIT. She leads the Gut-Brain Axis Laboratory, which collaborates extensively with researchers across institutions, particularly with Prof Ashley Franks at La Trobe University. The laboratory employs a multidisciplinary team with expertise in neuroscience, microbiology, immunology, and gastrointestinal physiology, utilizing advanced techniques to investigate the complex interactions between the nervous system, immune system, and gut microbiome.

Mark Morrisonمشاهده پروفایل

استاد مدعو

• Biomedical and Clinical Sciences
• Clinical microbiology
• Gastroenterology and hepatology
• +۳ مورد دیگر

Professor Mark Morrison is an Affiliate Professor at the School of Chemistry and Molecular Biosciences, University of Queensland, and holds roles as Chair & Group Leader of Metagenomics at the Frazer Institute within the Faculty of Health, Medicine and Behavioural Sciences. His research focuses on clinical microbiology, gastroenterology, and the microbiome’s role in diseases like inflammatory bowel disease (IBD) and diabetes. He has extensive academic qualifications, including a Bachelor of Science from the University of New South Wales, a Master’s from James Cook University, and a PhD from the University of Illinois. Education : Bachelor of Science, University of New South Wales Masters (Research) of Science, James Cook University Doctor of Philosophy, University of Illinois His research interests span microbiome-driven health and disease mechanisms, particularly in gut-brain interactions, mucosal microbiota dynamics, and translational therapies. Over 390 works include studies on dietary FODMAP effects, microbiome-based IBD diagnostics, and SCFA therapy for diabetes. He leads interdisciplinary grants on microbiome manipulation and has advised numerous PhD students on topics like Crohn’s disease, archaeal biodiversity, and immune modulation. His recent articles highlight microbiota roles in SIBO, anastomotic leaks, and probiotic efficacy. While no explicit awards are cited, his contributions to gut microbiome science are recognized through active research collaborations and funding. He actively supervises students and chairs teams advancing metagenomics and clinical applications.

Rachel J. Whitakerمشاهده پروفایل

استاد

• Archaeal Biology
• Bioinformatics
• Genome Organization
• +۷ مورد دیگر

Rachel J. Whitaker is the Harry E. Preble Professor in Liberal Arts and Sciences at the University of Illinois at Urbana-Champaign, affiliated with the Department of Microbiology in the College of Liberal Arts & Sciences . She leads the Whitaker Lab , studying microbial evolution, archaeal biology, and viral symbiosis. Her work focuses on CRISPR-Cas systems, microbial ecology, and infectious disease dynamics. Education: B.A. in Biology and Science in Society, Wesleyan University (1993) Ph.D. in Microbiology, University of California, Berkeley (2004) Postdoctoral Research in Geomicrobiology, UC Berkeley (2006) Research Interests: Whitaker’s team investigates archaeal genome evolution, viral-microbe interactions, and the role of CRISPR-Cas immunity in microbial ecosystems. Key areas include: Archaeal cell biology and physiology Phage-driven evolutionary dynamics in Pseudomonas aeruginosa One Health approaches to infectious disease Sulfolobus islandicus as a model organism Awards & Honors: Allen Distinguished Investigator Award (2017) University Scholar Award (2020) American Academy of Microbiology Fellow Co-Director, Microbial Diversity Course at Marine Biological Lab Advising & Grants: Whitaker oversees the Whitaker Lab and collaborates on initiatives like the Infection Genomics for One Health Theme at the Carl R. Woese Institute for Genomic Biology. Her work is funded by grants such as the Gordon and Betty Moore Foundation and NIH. Labs & Teams: Research is conducted in the Whitaker Lab , focusing on experimental evolution, genomics, and molecular biology. Partnerships include the Carl R. Woese Institute and the Marine Biological Lab.